Clinical Trial Update: A Study in MPS VI to Assess Safety and Efficacy of Odiparcil [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Odiparcil in Mucopolysaccharidosis VI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Vi

Drugs mentioned

• Odiparcil (odiparcil)

Snippet

Sponsor: Inventiva Pharma | Conditions: Mucopolysaccharidosis VI | Phase 2 | Status: COMPLETED